SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.
High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Sta...
| Autori principali: | , , , , , , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
2013
|
| _version_ | 1826285598903631872 |
|---|---|
| author | Chan, A Tetzlaff, J Gøtzsche, P Altman, D Mann, H Berlin, J Dickersin, K Hróbjartsson, A Schulz, K Parulekar, W Krleza-Jeric, K Laupacis, A Moher, D |
| author_facet | Chan, A Tetzlaff, J Gøtzsche, P Altman, D Mann, H Berlin, J Dickersin, K Hróbjartsson, A Schulz, K Parulekar, W Krleza-Jeric, K Laupacis, A Moher, D |
| author_sort | Chan, A |
| collection | OXFORD |
| description | High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders. |
| first_indexed | 2024-03-07T01:31:14Z |
| format | Journal article |
| id | oxford-uuid:93aaf12b-e3ae-4ba4-a2ff-fecbf1c090d3 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:31:14Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:93aaf12b-e3ae-4ba4-a2ff-fecbf1c090d32022-03-26T23:34:02ZSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:93aaf12b-e3ae-4ba4-a2ff-fecbf1c090d3EnglishSymplectic Elements at Oxford2013Chan, ATetzlaff, JGøtzsche, PAltman, DMann, HBerlin, JDickersin, KHróbjartsson, ASchulz, KParulekar, WKrleza-Jeric, KLaupacis, AMoher, DHigh quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders. |
| spellingShingle | Chan, A Tetzlaff, J Gøtzsche, P Altman, D Mann, H Berlin, J Dickersin, K Hróbjartsson, A Schulz, K Parulekar, W Krleza-Jeric, K Laupacis, A Moher, D SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. |
| title | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. |
| title_full | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. |
| title_fullStr | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. |
| title_full_unstemmed | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. |
| title_short | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. |
| title_sort | spirit 2013 explanation and elaboration guidance for protocols of clinical trials |
| work_keys_str_mv | AT chana spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT tetzlaffj spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT gøtzschep spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT altmand spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT mannh spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT berlinj spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT dickersink spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT hrobjartssona spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT schulzk spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT parulekarw spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT krlezajerick spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT laupacisa spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials AT moherd spirit2013explanationandelaborationguidanceforprotocolsofclinicaltrials |